CommSec's Tom Piotrowski speaks with AirXpanders (AXP) CEO, Scott Dodson about:

  • AXP’s AeroForm product, which offers a needle-free alternative for women who choose reconstructive surgery following a mastectomy. AeroForm is activated by a handheld wireless controller that administers small amounts of carbon dioxide up to three times a day, to gradually stretch the tissue in preparation for a breast implant.
  • The factors that have led to the growth in sales of AeroForm with the product now available in more than 100 medical institutions and health systems in the U.S.  
  • How AXP is driving increased awareness and enquiry for AeroForm through a successful public relations program.
  • AXP’s focus on increasing capacity at the contract manufacturing facility in Costa Rica.

To view other Executive Series interviews, visit (VIEW LINK)